# BRight Pharmacokinetic Study

> **NCT06065345** · NA · COMPLETED · sponsor: **Biotronik CRC Inc.** · enrollment: 6 (actual)

## Conditions studied

- Peripheral Artery Disease

## Interventions

- **DEVICE:** BRight DCB

## Key facts

- **NCT ID:** NCT06065345
- **Lead sponsor:** Biotronik CRC Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-05-01
- **Primary completion:** 2024-06-27
- **Final completion:** 2025-07-22
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2025-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06065345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06065345, "BRight Pharmacokinetic Study". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT06065345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*